LSHC Horizons Brochure 2024 - Flipbook - Page 45
Hogan Lovells | 2024 Life Sciences and Health Care Horizons | Transactions
45
Horizon Europe: Research and innovation funding in Europe
for life sciences and health care companies
The Horizon Europe program of the European
Union (EU) provides a substantial budget
of 95.5 billion EUR to fund research and
innovation until 2027. Horizon Europe offers a
range of funding opportunities and support for
the life sciences sector, especially in the areas
of health, food, bioeconomy, natural resources,
agriculture, and environment.
The Horizon Europe Program
Horizon Europe is the EU’s key framework
program for funding research and innovation in
areas that the EU considers essential for the EU’s
competitiveness, growth and implementation
of its strategic priorities. The overall budget of
the program, which runs from 2021 to 2027, is
95.5 billion EUR. Health is identified as one of
the key technology areas to be supported by the
program. The budget reserved for research and
development in the field of health technologies is
approx. 8.2 billion EUR.
Who is eligible for funding? Entities
from the EU and Associated Countries
Legal entities, which are established in an EU
Member State or in one of the currently 18
Associated Countries, including Israel, Norway,
Turkey, and the United Kingdom, are eligible
for funding.
Christian Stoll
Office Managing Partner
Hamburg
Affiliates and subsidiaries of non-eligible
parent companies are also eligible for funding if
the affiliate/subsidiary is established in an EU
Member State or an Associated Country and if
the applying entity is capable of performing the
research and innovative action.
In exceptional cases, the EU may even decide
that entities from non-associated countries,
such as the United States, are directly eligible
for funding.
Which actions are funded in the health
area and how much funding can be
awarded?
The EU publishes calls for proposals describing
the topic and objectives of the research, the
activities which should be included in the
proposal and the funding available for the
call. Within the framework of such calls
for proposals, applicants may submit their
proposals for research and innovation projects.
The funded projects are selected on the basis of
their excellence, impact, quality, and efficiency
of the implementation. If funding is awarded,
it may cover 70% or even up to 100% of the
eligible costs.
In the field of Health, the calls cover topics like
treatment of cancer, performance evaluation of
medical devices and in vitro diagnostics, new
approach methodologies for regulatory safety
and efficacy testing, antimicrobial resistance,
and new tools, technologies, and digital
health solutions.
Arne Thiermann LL.M. (LSE)
Partner
Hamburg
Summary
The Horizon Europe program provides an
attractive framework for obtaining funding for
research and innovation projects in the field of
health care and life sciences.
When planning new research projects,
innovative pharmaceutical, medtech and
biotech companies from both inside and
outside the EU should check whether Horizon
Europe funding may be available.
